Latest Company Strategy News

MetalsTech Limited’s substantial shareholders have finalized an off-market sale of 23.6 million shares, raising over $11 million and reshaping the company’s ownership landscape.

Stonehorse Energy has announced the immediate resignation of executive David Deloub following the termination of his services agreement, with the Executive Chairman stepping in to manage operations.

Jatcorp announces the immediate resignation of CEO Sunny Liang, appointing Executive Director Dr Sean Li as acting CEO during the search for a permanent replacement.

Platinum Capital Limited has received nominations for three new directors following a shareholder requisition, setting the stage for a pivotal general meeting. The company must now consider the appointments of Richard Caldwell, Julian Martin, and Geoff Wilson.

Orbminco Limited has announced the upcoming resignation of Managing Director Ralf Kriege, effective November 7, 2025, marking a significant leadership change for the copper and gold explorer.

Peet Limited has announced an extension of its on-market share buy-back program, with a remaining 2.68 million shares to be acquired over the next year. The buy-back will be managed by UBS Securities Australia Limited and is set to run from September 2025 to September 2026.

Environmental Clean Technologies has announced that CEO John Tranfield will resign effective 29 October 2025, with a transition period planned to support ongoing strategic initiatives.

The Takeovers Panel has issued interim orders requiring Bryah Resources to retain and provide detailed voting records from its upcoming general meeting, signaling heightened regulatory scrutiny amid shareholder tensions.

Octava Minerals Limited has had its trading suspension lifted following the announcement of a proposed capital raising, signaling renewed market activity for the mining explorer.

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Boom Logistics announces CEO Ben Pieyre's resignation, with a transition period extending to December 2025 as the company begins its search for new leadership.

Prescient Therapeutics has initiated its first US clinical site for the PTX-100 Phase 2a trial targeting Cutaneous T-Cell Lymphoma, marking a key milestone in expanding patient recruitment beyond Australia.